Altre lingue Ventripoint Diagnostics Ltd.

Azioni

VPT

CA92281P2008

Mercato chiuso - Toronto S.E. Altri mercati azionari 21:58:32 17/05/2024			Variaz. 5gg	Var. 1 gen.
0,22 ^CAD	0,00%		-10,20%	-25,42%

30/04	Ventripoint Diagnostics Ltd. Ventripoint Diagnostics Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
04/03	Ventripoint Diagnostics Ltd. rilascia un aggiornamento significativo del design e delle funzioni del suo sistema di analisi del cuore intero (VMS+3.2)	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Ventripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug Administration	06/05
Duke University Health Center -- One of America's Top Heart-care Institutions and Innovators -- Purchases Ventripoint's AI Heart-scan Technology	01/05
Ventripoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
VentriPoint Diagnostics Ltd. announced that it expects to receive CAD 3 million in funding	11/04
Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call	28/03
Ventripoint Diagnostics Ltd. Releases Significant Upgrade to the Design and Function of Its Whole-Heart Analysis System (VMS+3.2)	04/03
Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use	04/03
Ventripoint Diagnostics Ltd. Showcases A.I. Powered Heart-Scanning Technology at International Cardiology Conferences	20/02
Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences	20/02
Ventripoint Announces Changes to The Board of Directors	13/02
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as Interim CEO	05/02
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as President	05/02
Ventripoint Begins 2024 with Leadership Change	05/02
The Paediatric Heart Centre At the Medical University of Vienna Has Chosen to Adopt the Vms+ as Its Cardiac Diagnostic Tool	01/02
The Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging System	01/02
The 2023 Year in Review	29/01
Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint's Clinical Advisory Board	22/01
VentriPoint Diagnostics Ltd. Announces Appointment of Dr. Luc Mertens to Clinical Advisory Board	21/01
Rising Nanocap Stars of Medical Technology (TBRIF, PROF, VPTDF, ATBPF)	04/01
Ventripoint Whitepaper Distribution	03/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ventripoint Diagnostics Ltd.

Azioni

VPT

CA92281P2008

Altre lingue

Filtri